1. He, Ruizhe, Shi, Juanjuan, Xu, Dapeng, Xue, Jing, Liu, Wei. 2022. SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer. In Cancer letters, 538, 215693. doi:10.1016/j.canlet.2022.215693. https://pubmed.ncbi.nlm.nih.gov/35472437/
2. Hennigs, Jan K, Cao, Aiqin, Li, Caiyun G, Snyder, Michael P, Rabinovitch, Marlene. 2020. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. In Circulation research, 128, 401-418. doi:10.1161/CIRCRESAHA.119.316339. https://pubmed.ncbi.nlm.nih.gov/33322916/
3. Huang, Jianhua, Li, Cheng, Zhang, Wentao, Li, Wei, Yao, Xudong. . SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis. In Annals of translational medicine, 9, 1439. doi:10.21037/atm-21-4102. https://pubmed.ncbi.nlm.nih.gov/34733991/
4. Yan, Jiusong, Xie, Xiaodu, Li, Qinke, Zhang, Junyong, Xu, Guangyong. 2023. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma. In Heliyon, 9, e13613. doi:10.1016/j.heliyon.2023.e13613. https://pubmed.ncbi.nlm.nih.gov/36852051/
5. Lui, Natalie S, Yang, Yi-Wei, van Zante, Annemieke, Jablons, David M, Lemjabbar-Alaoui, Hassan. 2016. SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer. In PloS one, 11, e0148911. doi:10.1371/journal.pone.0148911. https://pubmed.ncbi.nlm.nih.gov/26882224/
6. Guo, Xiaolan, Lin, Yuyin, Lin, Yingnan, Zhang, Qian-Qian, Dai, Jianwei. 2022. PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification. In Environmental pollution (Barking, Essex : 1987), 303, 119115. doi:10.1016/j.envpol.2022.119115. https://pubmed.ncbi.nlm.nih.gov/35259473/
智鼠故事 
